Paula Jakszyn holds a Nutrition degree (University of Buenos Aires, 1999), a Master in Public Health (Pompeu Fabra University-UPF, 2004) and a PhD in Health and Life Sciences (Pompeu Fabra University-UPF, 2006).
In 2002 she joined the Epidemiology Research Program (PREC) in the Catalan Institute of Oncology (ICO), where she has built her career as researcher in nutritional epidemiology and cancer for more than 15 years. After a predoctoral stage in the prestigious group of Dr Sheila Bingham in Cambridge, UK (2005), she obtained her PhD with a research topic focused on the relationship between meat, nitrosamines and gastric cancer.
In 2012 she started leading her own research in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, an international, multicentric research project focused on the effects of diet, nutritional status, lifestyle and environmental factors in the incidence of cancer and other chronic diseases. She has won several competitive research projects from consolidated public and private research institutions and consortiums such as the Institute of Health Carlos III (ISCIII the Marató de TV3 Foundation, or the World Cancer Research Fund, and she has coordinated a work package within the European Cooperation Network in Oncology (ONCONET SUDOE) for the launching of two free online courses in nutrition, physical activity and cancer in the web-based, e-learning platform e-oncología.
She is currently leading a multidisciplinary group composed of senior investigators, statisticians and nutritionists, as well as master and undergraduate students. The long and extensive research activity made by her group has resulted in more than 100 scientific publications, as well as several PhD and Master thesis obtained.
She is also Associate Professor in the Blanquerna Faculty of Health Sciences in the Ramon Llull University (FCSB-URL) and in the Master of Public Health in Pompeu Fabra University-UPF. She is currently a member of the Ethics Committee of the FCSB and an academic member of the Spanish Academy of Nutrition and Dietetics.
Jakszyn P, Cayssials V, Buckland G, et al. Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2020 Aug 15;147(4):1027-1039. doi: 10.1002/ijc.32870
Agudo A, Cayssials V, Bonet C, (…) Jakszyn P. Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2018 Apr 1;107(4):607-616. doi: 10.1093/ajcn/nqy002
Jakszyn P, Fonseca-Nunes A, Lujan-Barroso L, et al. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study. Int J Cancer. 2017 Sep 1;141(5):945-951. doi: 10.1002/ijc.30797
Fonseca-Nunes A, Agudo A, Aranda N, (…) Jakszyn P. Body iron status and gastric cancer risk in the EURGAST study. Int J Cancer. 2015 Dec 15;137(12):2904-14. doi: 10.1002/ijc.29669
Agudo A, Fonseca-Nunes A, Jakszyn P. Systematic review and meta-analysis on iron and cancer risk-response. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1436-7. doi: 10.1158/1055-9965.EPI-14-0339
Agudo A, Bonet C, Sala N, (…) Jakszyn P. Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis. 2013 Jun;34(6):1244-50. doi: 10.1093/carcin/bgt045
Jakszyn P, Luján-Barroso L, Agudo A, et al. Meat and heme iron intake and esophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2013 Dec 1;133(11):2744-50. doi: 10.1002/ijc.28291
Jakszyn P, Agudo A, Lujan-Barroso L, et al. Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study. Int J Cancer. 2012 Jun 1;130(11):2654-63. doi: 10.1002/ijc.26263
Jakszyn P, González CA, Luján-Barroso L, et al. Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):555-9. doi: 10.1158/1055-9965.EPI-10-0971